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Abstract 
This paper deal with the synthesis and characterization of PEGylated squalene-grafted-inulin 
amphiphile capable of self-assembling and self-organizing into nanocarriers once placed in aqueous 
media. It was exploited as coating agent for obtaining doxorubicin loaded superparamagnetic iron 
oxide nanoparticles (SPIONs) endowed with stealth like behavior and excellent physicochemical 
stability. Inulin was firstly modified in the side chain with primary amine groups, followed in turn by 
conjugation with squalenoyl derivatives through common amidic coupling agents and PEGylation by 
imine linkage. Polymer coated SPIONs were so obtained by spontaneous self-assembling of inulin 
copolymer onto magnetite surface involving hydrophobic–hydrophobic interactions between the 
metallic core and the squalene moieties. The system was characterized in terms of hydrodynamic 
radius, zeta potential, shape and drug loading capacity. On the whole, the stealth-like shell stabilized 
the suspension in aqueous media, though allowing the release of the doxorubicin loaded in 
therapeutic range. The cytotoxicity profile on cancer (HCT116) cell line and in vitro drug uptake were 
evaluated both with and without an external magnetic field used as targeting agent and uptake 
promoter, displaying that magnetic targeting implies advantageous therapeutic effects, that is 
amplified drug uptake and increased anticancer activity throughout the tumor mass. 
 
Introduction 
 
Therapeutic approaches used to eradicate tumors involve invasive processes, long term largely 
ineffective, such as surgical removal of neoplastic mass [1]. The surgical therapy often needs further 
treatments during the follow-up, encompassing chemotherapy or radiotherapy [2]. The latter, even 
though it is the most localized technique, entails several drawbacks, among which, repeated 
treatments and secondary effects (e.g., sterility and side tumor genesis) [3]. In addition, current 
chemotherapy fails in many cases because of the recurrence of metastases or heavy toxic effects. 
These therapeutic limitations are mainly due to the lack of selective drug accumulation into the tumor 
site, thus affecting healthy cells as well [4] and [5]. The use of nanocarriers, designed to enhance 
drugs efficiency, permits to overcome some of these matters being drugs released into a specific 
body district. Several systems have been developed so as to act as drug delivery systems useful for 
targeted therapy, such as polymeric micelles [6], [7] and [8] liposomes [9], polymersomes [10], 
polymeric nanoparticles [11] and [12], and magnetic nanoparticles [1]. 
Magnetic nanoparticles represent an innovative class of nanocarrier which has proved capable of 
targeting anticancer drugs, avoiding the most part of limitations attributable to conventional 
therapeutic tools. Such systems imply improved bioavailability in the tumor site by means of a double 
targeting effect, namely enhanced permeability retention effect (EPR) [13] and [14] (passive) and the 
magnetic targeting owing to the attraction to an external magnetic field. The advantages above 
reported lead to other benefits, including reduced toxicity toward healthy cells and the ability to 
locally deliver a high drug payload into tumor mass. Superparamagnetic iron oxide nanoparticles 
(SPIONs) are a unique family of magnetic nanoparticles endowed with additional advantageous 
physicochemical properties. Specifically, they show magnetic interactions that do not persist once 
the external magnetic field is removed (superparamagnetism) [15], and hence site specific magnetic 
targeting can be efficiently obtained applying onto the tumor mass removable and nontoxic magnetic 
fields as external drawing force. 
SPIONs consist of a solid core made up of iron oxides (magnetite, Fe3O4 and/or maghemite, Fe2O3) 
mostly coated with biocompatible polymers. Typically, the coating agent plays a double role, which 
is to protect nanoparticles from oxidation and increase their stability when dispersed in aqueous 
media. Indeed, the presence of a hydrophilic shell avoids hydrophobic–hydrophobic interactions that 
provoke SPIONs aggregation, so nullifying all advantages related to the nanomeric dimensions of the 
starting carrier [16]. Many natural and synthetic polymers such as poly(hydroxyethyl) aspartamide 
derivative [17] and [18], chitosan, ethyl cellulose, poly(lactide) acid, poly(lactide-co-glycolide) acid 
and poly(ethylene)glycol have been employed as coating agents for enhancing SPIONs stability and 
conferring surface functional groups available for further reactions [19] and [20]. However, some of 
these either are not sufficiently bioeliminable or degrade to acidic products often yielding to local 
inflammation. Therefore, new cost-effective polymers provided with excellent biocompatibility and 
versatility should be synthesized and studied in view of clinical applications [20], [21] and [22]. 
In this study we propose inulin-based copolymer as coating agent for SPIONs. Inulin is a natural, 
biocompatible, bioeliminable and biodegradable [23] polysaccharide consisting of linear chains of β-
(2-1) fructose units and typically has a glucose unit attached at the reducing end. It is water soluble 
and exhibits high hydroxyl functional groups available for common coupling reactions [24]. Various 
studies have dealt with its chemical modification in order to obtain biocompatible drug delivery 
systems (DDS), including hydrogels [25], nanoparticles [26], micelles [6] and [27], and 
macromolecular bioconjugates [28]. Being inulin versatile and highly functionalizable [29] and [30], 
here we focused our attention on the synthesis of an amphiphilic inulin derivative capable of coating 
SPIONs once placed in aqueous media. We demonstrated that the polymer-coated SPIONs loaded 
significant amounts of doxorubicin during the self-assembling process, which was released at 
physiological conditions in a controlled fashion so acting as an excellent anticancer system. Under 
the effect of external magnetic stimuli, it was also assessed the ability of the system to be 
accumulated into a specific area mimicking its potential targeting effect in the human body. 
 
2. Experimental part 
2.1. Materials and methods 
 
Squalene (purity > 99%) was purchased from VWR (Italy). Inulin-(2-aminoethyl)-carbamate (INU-
EDA), used as starting copolymer, was synthesized as previously reported [6]. Inulin, triethylamine 
(TEA), ethylenediamine (EDA), Bis(4-nitrophenyl)carbonate (BNPC), doxorubicin hydrochloride 
(DOXO-HCl), iron oxide (Fe3O4) magnetic nanoparticles (10 ± 1 nm) in water, iron(III)chloride, 
ferrozine (3-(2-pyridyl)-5,6-bis(phenyl sulfonic acid)-1,2,4-triazine), and neocuproine (2,9-
dimethyl(1,10-phenanthroline)), were purchased from Aldrich (Milan, Italy). N-hydroxysuccinimide 
(NHS), 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC-HCl), O-[2-(6-
oxocaproylamino)-ethyl]-O′-methylpolyethylene glycol 2000 (PEG-CH O), Sephadex G-15, 
anhydrous dimethylformamide (DMF), were purchased from Fluka (Switzerland). All reagents were 
of analytic grade, unless otherwise stated. SpectraPor dialysis tubing was purchased from Spectrum 
Laboratories, Inc. (Italy). 
The 1H NMR spectra were recorded using a Bruker Avance II 300 spectrometer operating at 300 MHz. 
Fluorescence spectroscopy was performed by using a Shimadzu RF-5301 PC spectrofluorimeter. 
Centrifugations were performed using a Centra MP4R IEC centrifuge. Size exclusion chromatography 
(SEC) was carried out using a Phenomenex PolySep-GFC-P3000 column (California, USA) connected 
to a Water 2410 refractive index detector. Phosphate buffer pH 6.5/methanol 9:1 (v/v) solution was 
used as eluent at 35 °C with a flux of 0.6 mL/min, and pullulan standards (112.0–0.18 kDa, Polymer 
Laboratories Inc., USA) were used to set up calibration curve. 
 
2.2. Synthesis of 1,1′,2-tris-nor-squalene acid (SqCOOH-C27): (4E,8E,12E,16E)-4,8,13,17,21-
pentamethyl-4,8,12,16,20-docosapentaenoic acid 
1,1′,2-Tris-nor-squalene aldehyde [31], [32] and [33] (1.58 g, 4.12 mmol) was dissolved in diethyl 
ether (20 mL) at 0 °C. Separately, sulfuric acid (2.3 mL) was added at 0 °C to distilled water (20 mL) 
with stirring, followed by potassium dichromate (1.21 g, 4.12 mmol) to obtain chromic acid. It was 
then added at 0 °C within 20 min to the solution of 1,1′,2-tris-nor-squalene aldehyde, previously 
prepared, and left to react for 2 h at 0 °C with stirring. The reaction mixture was extracted with diethyl 
ether (50 mL × 3), washed with saturated brine, dried over anhydrous sodium sulfate and evaporated 
in vacuum. The completion of the reaction was revealed by silica gel TLC with light petroleum/diethyl 
ether/methanol, 70:23:7. The crude product was purified by flash chromatography with light 
petroleum, then light petroleum/diethyl ether, 95:5 as eluent, to give 578 mg of 1,1′,2-tris-nor-
squalene acid (35% yield), as a colorless oil. 
1H NMR spectra were recorded on a Bruker 300 ultrashield instrument (Karlsruhe, Germany) for 
samples in CDCl3 solution at room temperature, with Me4Si (TMS) as internal standard. Coupling 
constants (J) are given in Hz. Mass spectra were recorded on a Finnigan MAT TSQ 700 spectrometer 
(San Jose, CA). The reactions were monitored by TLC on F254 silica gel precoated sheets (Merck, 
Damstadt, Germany); after development, the sheets were exposed to iodine vapor. Flash-column 
chromatography was performed on 230–400 mesh silica gel. 
1H NMR (CDCl3): δ, 1.55–1.63 (m, 18 H, allylic CH3), 1.90–2.05 (m, 16 H, allylic CH2), 2.26 (t, 2 H, 
CH2CH2COOH), 2.38 (t, 2 H, CH2CH2COOH), 5.00–5.19 (m, 5 H, vinylic CH), 12.20 (broad, 1 H, COOH). 
MS (EI): m/z 400 (M+, 5), 357 (3), 331 (5), 289 (3), 208 (6), 136 (3), 81 (100). 
 
2.3. Synthesis of Inulin-1,1′,2-tris-nor-squalene (INU-Sq) 
SqCOOH-C27 (12 mg, 1.5 × 10−2 mmol) was solubilized in DMF (1.2 mL), and then EDC-HCl (3.6 mg, 
1.9 × 10−2 mmol) was added. After that, NHS (2.2 mg, 1.9 × 10−2 mmol) and TEA (3 μL, 2.1 × 10−2 mmol) 
were added to the reactive mixture at once together and the reaction was kept 4 h at 40 °C. The 
resulting solution was added to 4 mL of a INU-EDA solution in DMF (25 mg/mL) drop-wise and left to 
react at 25 °C for 18 h. The INU-Sq conjugate was then precipitated in diethyl ether/dichloromethane 
mixture (2:1 vol/vol) and collected by centrifuging at 5 °C for 5 min, at 9000 rpm. The solid residue 
was then washed four times with the same mixture. The obtained solid product was dried under 
vacuum and weighted. INU-Sq was obtained with a yield of 95% (w/w) based on the starting inulin. 
The obtained copolymer was characterized by 1H NMR (300 MHz, D2O/DMF-d7 (5:1): δ 1.12–1.52 
(18H, squalenoyl allylic CH3), 1.91–2.21 (16H, squalenoyl allylic CH2), 2.9–3.1 (4HEDA, NH CH2
CH2 NH ), 3.55–4.0 (5HINU, CH2 OH; CH CH2 OH; C CH2 O ), 4.02–4.19 
(2HINU, C CH OH; CH OH). 
 
2.4. Synthesis of = inulin-1,1′,2-tris-nor-squalene-PEG2000 (INU-Sq-PEG2000) graft copolymer 
PEG-CHO (21 mg, 1.05 × 10−2 mmol) was added to 4 mL of INU-Sq aqueous solution (22.5 mg/mL) at 
pH 6.8. The pH of the reaction mixture increased slowly, and consequently the pH of the reaction was 
kept at 6.8 using 0.1 N hydrochloric acid. The mixture was left with stirring at room temperature 
overnight. Then it was dried by vacuum and the crude reaction was washed up with diethyl 
ether/dichloromethane mixture 2:1 vol/vol (4 × 40 mL). The solid product was dried under vacuum 
yielding a white solid. Yield 85% with respect to the starting inulin. The obtained graft copolymer was 
characterized by 1H NMR (300 MHz, D2O/DMF-d7 (2:1): δ 1.12–1.53 (18H, squalenoyl allylic CH3), 
1.96–2.22 (16H, squalenoyl allylic CH2), 2.93–3.07 (4HEDA, NHCH2 CH2 NH), 3.65 (176HPEG2000, OCH2 CH2
O), 3.67–3.88 (5HINU, CH2 OH; CHCH2 OH; CCH2 O), 3.90–4.20 (2HINU, CCHOH; CHOH). 
 
2.5. Preparation of INU-Sq-PEG2000 coated SPIONs (IC-SPIONs) 
To an aqueous suspension of Fe3O4 (5 mg/mL) INU-Sq-PEG2000 copolymer (50 mg) was added with 
gentile stirring. The obtained mixture was sonicated in an ultrasonic bath for 10 min, thus diluted to 
5 mL with double distilled water and, finally, placed into dialysis tube (Spectra Por, Float-A-Lyzers) 
with a nominal molecular weight cut-off (NMWCO) 8–10 kDa. After 48 h IC-SPIONs were freeze-dried 
and obtained as a brownish powder. Yield 100%. 
 
2.6. Preparation of doxorubicin loaded IC-SPIONs (Doxo-IC-SPIONs) 
Analogous procedure was adopted for the preparation of doxorubicin loaded magnetic nanoparticles 
(Doxo-IC-SPIONs). For the drug loading, 1 mL of an aqueous doxorubicin hydrochloride solution 
(10 mg/mL, 1.7 × 10−2 mmol), previously treated with TEA (10 μL, 7 × 10−2 mmol), was added to the 
polymer/Fe3O4 mixture before starting the sonication. The obtained mixture was sonicated in an 
ultrasonic bath for 10 min and then placed into dialysis tube (Spectra Por, Float-A-Lyzers) with a 
nominal molecular weight cut-off (NMWCO) 8–10 kDa. After 48 h Doxo-IC-SPIONs were freeze-dried 
and obtained as a brownish powder. Yield 70%. 
  
 2.7. Characterization of the nanosystems 
2.7.1. Scanning electron microscopy (SEM) 
For the morphology studies, freeze-dried IC-SPIONs were visualized using a scanning electron 
microscope, ESEM Philips XL30. Samples were dusted on a double sided adhesive tape previously 
applied on a stainless steel stub. The IC-SPIONs were then sputter-coated with gold prior to 
microscopy examination. 
 
2.7.2. Dynamic Light Scattering (DLS) measurement and Z-potential analysis 
DLS studies and Z-potential measurements (mV) were performed at 25 °C using a Malvern Zetasizer 
NanoZS instrument, fitted with a 532 nm laser at a fixed scattering angle of 173°. Aqueous solutions 
of IC-SPIONs and Doxo-IC-SPIONs (0.2 mg/mL), were analyzed after filtration through a 5 μm cellulose 
membrane filter. The intensity-average hydrodynamic diameter and polydispersity index (PDI) were 
obtained by cumulants analysis of the correlation function. The zeta potential (mV) was calculated 
from the electrophoretic mobility using the Smoluchowski relationship and assuming thatK · a ≫ 1 
(where K and a are the Debye–Hückel parameter and particle radius, respectively). 
 
2.7.3. FT-IR analysis 
Investigation of the general and quantitative composition of polymer coated iron oxide nanoparticles 
were carried out via infrared spectroscopy (FT-IR). The spectra of INU-Sq-PEG2000 copolymer, IC-
SPIONs and solid SPIONs were recorded in KBr pellets in the frequency range of 4000–400 cm−1 by 
using a Perkin-Elmer Spectrum RX I FT-IR system spectrophotometer. Spectra were recorded in 
transmittance scale (%T) with a resolution of 1 cm−1 and a number of scans = 100. 
 
2.7.4. Total iron determination 
The iron content in IC-SPIONs and Doxo-IC-SPIONs was measured using the Ferrozine-based 
spectrophotometric iron estimation method [17]. For this method freeze-dried IC-SPIONs (5 mg) or 
Doxo-IC-SPIONs (5 mg) were dispersed in 1.4 N hydrochloric acid (1 mg/mL) and kept for 2 h at 60 °C 
in a water bath to allow the disaggregation of nanoparticles and complete dissolution of the 
Fe3O4 nanoparticles. After that, 1 mL of iron-detection reagent (6.5 mM ferrozine, 6.5 mM 
neocuproine and 1 M acid ascorbic dissolved in acetate buffer at pH 4.5) was added to the iron 
solution and incubated for 30 min at room temperature. Then, the optical density of the sample was 
measured at 560 nm using a Shimadzu UV-2401PC spectrophotometer, and the concentration of 
Fe3O4 was calculated by comparing this value with a calibration curve obtained by recording the 
absorbance of FeCl3 standard solutions (ranging from 0.5 to 5 μg/mL). Water with iron-detection 
reagent was used as blank. 
  
 2.7.5. Determination of drug payload into Doxo-IC-SPIONs and drug release studies 
The amount of doxorubicin loaded into Doxo-IC-SPIONs was determined by UV spectroscopy 
measuring the absorbance at 480 nm of the sample, prepared by dispersing known amounts of these 
in double distilled water at pH ∼ 6. A calibration curve was obtained for serially diluted 
concentrations of doxorubicin hydrochloride in bidistilled water at pH ∼ 6. The content of drug 
loaded into the system was expressed as the amount of loaded doxorubicin per unit mass of dry 
nanoparticles, and resulted to be 11.6 ± 0.5% (w/w), while the encapsulation efficiency was 
calculated to be 58.5%. 
For drug release studies, an appropriate amount of freeze dried Doxo-IC-SPIONs (5 mg) was 
suspended in PBS at pH 7.4 (5 mL) and placed into floating dialysis tubing with a MWCO 1 kDa. This 
dialysis membrane was immersed into PBS at pH 7.4 (15 mL) and incubated at 37 °C under continuous 
stirring (100 rpm) in a Benchtop 808C Incubator Orbital Shaker model 420, for 48 h. At scheduled 
time intervals, aliquots of the external medium (1 mL) were withdrawn from the outside of the 
dialysis membrane and replaced with equal amount of fresh medium. The withdrawn samples were 
analyzed by HPLC in order to determine the released drug. Profile releases were determined by 
comparing the amount of released drug as a function of incubation time with the total amount of 
drug loaded into the Doxo-IC-SPIONs. The same analysis was carried out using PBS at pH 5.5. All 
release data were compared with the diffusion profile of doxorubicin hydrochloride alone (0.62 mg) 
obtained by using the same procedure. 
Data were corrected taking in account the dilution procedure. Each experiment was carried out in 
triplicate and the results were in agreement within ±5% standard error. 
 
2.8. Cytotoxicity assay on human colon cancer (HCT116) cells 
The cytotoxicity was assessed by the MTS assay on human colon cancer (HCT116) cell lines 
(purchased from Istituto Zooprofilattico Sperimentale della Lombardia e dell’ Emilia Romagna, Italy), 
using a commercially available kit (Cell Titer 96 Aqueous One Solution Cell Proliferation assay, 
Promega). Cells were seeded in 96 well plate at a density of 2.5 × 104 cells/well and grown in 
Dulbecco’s Minimum Essential Medium (DMEM) with 10% FBS (fetal bovine serum) and 1% of 
penicillin/streptomycin (10,000 U/mL penicillin and 10 mg/mL streptomycin) at 37 °C in 5% 
CO2 humidified atmosphere. After 24 h the medium was replaced with 200 μL of fresh culture 
medium containing empty IC-SPIONs and Doxo-IC-SPIONs at a concentration per well equal to 0.13, 
0.27, 0.54, 0.81 and 1.08 mg/mL, corresponding to 25, 50, 100, 150 and 200 μM of doxorubicin. 
Moreover, the same experiment was performed applying a permanent magnets (attraction force of 
250 g) at the bottom of the wells, and using a concentration of empty IC-SPIONs and Doxo-IC-SPIONs 
of 0.27 mg/mL (equivalent to 50 μM of doxorubicin). Additionally, cells treated with the same magnet 
were used as negative control for exposition to external magnetic field. After 24 and 48 h, DMEM 
was replaced with 100 μL of fresh medium, and 20 μL of a MTS solution was added to each well. 
Plates were incubated for additional 2 h at 37 °C. Then, the absorbance at 490 nm was measured 
using a microplate reader (Multiskan, Thermo, UK). Doxorubicin hydrochloride solutions at the same 
concentrations were used as a positive control, as pure cell medium was used as a negative control. 
Results were expressed as percentage reduction of the control cells. All culture experiments were 
performed in triplicates. 
 
2.9. Cell drug uptake studies 
The cellular uptake of the Doxo-IC-SPIONs was evaluated by fluorescence microscopy analysis (Zeiss 
“AXIO Vert. A1” Microscope Inverted). HCT116 cell line, 2.5 × 104 cells/well, maintained in normal 
medium were cultured in a 46 well plate at 37 °C in an atmosphere of 5% CO2 for 24 h. After 24 h the 
medium was replaced with 200 μL of fresh culture medium containing Doxo-IC-SPIONs or free 
doxorubicin hydrochloride at final drug concentration of 50 μM, and thus cells were incubated for 4, 
24 and 48 h. This experiment was performed with or without an external magnetic field. For the 
experiments in the presence of an external magnetic field, permanent magnets with an attraction 
force of 250 g, were fixed to the bottom of the wells containing the cells. After each incubation 
period, the medium was removed and the cell monolayer was washed twice with DPBS and fixed with 
4% formaldehyde for 30 min. Subsequently, the formaldehyde solution was removed, and the cells 
washed with DPBS and the nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI). After 
incubation, DAPI solution was removed, and the cells were washed with DPBS and observed by 
fluorescence microscope. The images were recorded using an Axio Cam MRm (Zeiss). 
 
2.10. Statistical analysis 
A one way analysis of variance (ANOVA) was applied to compare different groups. Data were 
considered statistically significant with a value of P < 0.05 and differences between the groups were 
compared using a posteriori Bonferroni t-test. All values are the average of three 
experiments ± standard deviation. 
 
3. Results and discussion 
3.1. Synthesis of inulin-graft co-polymers 
INU-Sq-PEG2000 is an amphiphilic polysaccharide based graft-copolymer useful for the preparation of 
self-assembled nanocarriers or as coating material of colloidal nanoparticles. In a previously 
published article [6], a similar copolymer carrying ceramide tails have been already studied for the 
preparation of polymeric micelles. Herein, being hydrophobic interactions useful only to stabilize the 
polymeric coating by the London dispersion forces, the synthesis of this copolymer was basically 
adapted in order to obtain a copolymer bearing squalenoyl branches as biocompatible hydrophobic 
moieties, conferring appropriate hydrophobicity still maintaining a good biocompatibility.[34] 
Inulin (α-D-glucopyranosyl-[β-D-fructofuranosyl](n-1)-D-fructofuranoside), a linear polysaccharide 
consisting of glucopyranose end-capped fructose units (β-1,2), was used as main biocompatible 
polymeric backbone. First of all, it was partially functionalized with EDA so as to introduce primary 
amine pendants that can be utilized as versatile functional groups allowing further 
functionalization [6]. A derivatization degree in EDA of 28% was obtained (DDEDA, 28 mol%, related to 
inulin monomer units). 
A squalene derivative (SqCOOH-C27) carrying a carboxylic functional group available for additional 
coupling reactions was synthesized starting from 1,1′,2-tris-nor-squalene aldehyde. After the usual 
work-up, SqCOOH-C27 was obtained in 35% yield. From the 1H NMR analysis, the presence of a 
characteristic signal of the carboxylic acid at 12.20 ppm, along with the observation of a shift of the 
vicinal hydrogens (CH2 CH2 COOH) observed at 2.26 ppm and 2.38 ppm respectively, confirmed the 
feasibility of the reaction. Furthermore, the molecular ion of the product (M+) observed at 400m/z by 
means of EI-MS analysis confirmed the hypothesis of the structure expected for the product. 
In a second step, INU-EDA was functionalized with the squalenoyl derivative (SqCOOH-C27) via amidic 
bond. In particular, SqCOOH-C27 was primarily activated using a mixture of EDC and NHS as coupling 
agents (Scheme 1). The stoichiometric conditions employed (moles of SqCOOH-C27/moles of amino 
pendant groups in INU-EDA = 0.1; moles of EDC-HCl/moles of SqCOOH-C27 = 1.2 and moles of 
NHS/moles of SqCOOH-C27 = 1.2) were fixed to obtain a quantitative conversion of the SqCOOH-
C27 carboxylic functions to amide. 
 
Scheme 1 - Synthesis of INU-Sq. 
 
The 1H NMR allowed an easy quantification of the SqCOOH-C27 linked to inulin, by comparing the 
integral of the peaks at δ 1.12–1.52 and at 1.91–2.21, ascribable to squalenoyl allylic CH3 and allylic 
CH2 respectively, to that belonging to the protons of INU backbone at δ comprised between 3.55 and 
4.19. The molar percent of SqCOOH-C27covalently linked to inulin (DDSq%) was equal to 1.7 ± 0.5 mol% 
referred to the inulin repeating units. The INU-Sq conjugates still maintain a large number of primary 
amine groups available for some potential subsequent side chain functionalization (about 90 mol% 
with respect to the total amount of amines), such as PEGylation. Hence, the last synthetic step was 
the synthesis of PEGylated INU derivative (INU-Sq-PEG2000). In that reaction a semitelechelic aldehyde 
functionalized mono-methoxy PEG, having an weigh average molecular weight of 2000 Da, was 
selected to easily react in a slightly acidic aqueous medium with the primary amine groups available 
in the polymer side chain, yielding to the immine bounds (see Scheme 2). 
 
Scheme 2 - Synthesis of INU-Sq-PEG2000 (n = 45). 
 
INU-Sq-PEG2000 copolymer was characterized by means of 1H NMR spectroscopy, which confirmed the 
introduction of PEG2000 chains on the INU-Sq backbone and allowed the calculation of the molar 
derivatization degree (DDPEG%). The DDPEG%, indicated as percentage of linked polyethylene chains in 
comparison with the repeating units of inulin, was calculated by comparing the integral of the peak 
related to protons at δ3.65 assigned to ethylene protons of PEG, with the integral of the peaks related 
to protons of INU backbone at δ comprised between 3.67 and 4.20. The DDPEG% was equal to 
2.7 ± 0.5 mol% referred to the inulin repeating units. 
Weight average molecular weights (Mw) and polydispersity of the synthesized copolymers were 
determined by SEC analyses and data are reported in Table 1. The relative Mw of the polymers was 
obtained using a calibration curve of monodisperse pullulan standards with Mw ranging from 200 to 
10,000. Definitively, the molecular weight increment of INU-Sq and INU-Sq-PEG2000 with respect to 
the starting INU-EDA copolymer confirm the derivatization of INU-EDA with Sq firstly and, 
subsequently, with PEG2000. After the derivatization of inulin with EDA, a drastic molecular weight 
abatement was observed, passing from 4.9 kDa to 2.5 kDa. This might be ascribed to several factors. 
In first instance, conformational changes of the polymer chain, caused by the introduction of 
ionisable amine groups into the polymer backbone, imply variations in the hydrodynamic radii of the 
copolymers. On the other hand, microwave assisted reactions can entail the degradation of the main 
polymer chain, thus leading to a polymer with lower molecular weight [6]. Similar behavior was 
observed after the introduction of Sq moieties in the main backbone. 
Table 1. 
Molar derivatization degree values of EDA, Sq and PEG linked to inulin and molecular weight (Mw) and dispersity of the 
correspondent copolymers. 
 
Copolymers 
Composition 
 
bMw (kDa) bDispersity Mw/Mn aDDEDA% aDDSq% aDDPEG% 
Inulin – – – 4.9 1.3 
INU-EDA 28 ± 1 – – 2.5 1.8 
INU-Sq 28 ± 1 1.7 ± 0.5 – 3.1 1.3 
INU-Sq-PEG2000 28 ± 1 1.7 ± 0.5 2.7 ± 0.5 4.3 1.2 
a - Calculated by means of 1H NMR spectroscopy 
b - Calculated by SEC analysis. 
 
3.2. Preparation and characterization of IC-SPIONs 
Polymeric coated iron oxide nanoparticles were obtained adding INU-Sq-PEG2000copolymer to iron 
oxide nanoparticles water dispersion dropwise. The simultaneous presence in the aqueous phase of 
both SPIONs, which are negatively charged (Z-potential = −29.2 ± 4 mV), and the cationic amphiphilic 
copolymers (Z-potential = +16 ± 5 mV) involves the adsorption of the latter on the surface of the iron 
oxide nanoparticle, thus acting as hydrocolloidal coating yielding to the stabilization of SPIONs in 
aqueous media. The drawing force that allows the IC-SPIONs formation is the ionic interaction 
established between SPIONs and INU-Sq-PEG2000 copolymer, as the Van der Waals interactions, with 
particular emphasis to the London dispersion forces, imply the assembling of the hydrophobic 
moieties of the amphiphiles adsorbed onto the nanoparticles, which stabilize and consolidate the 
nano-aggregates. 
Fig. 1 shows the morphology of IC-SPIONs obtained by high resolution SEM analysis. SEM micrographs 
showed a homogeneous spherical nanoparticles population and with a diameter of about 50 nm. 
 
 
Fig. 1 - SEM images of IC-SPIONs. 
 
These data were toughen up by DLS measurements which proved that the particle size observed by 
SEM have an average hydrodynamic diameter value of 54.79 nm and a PDI of 0.12 in aqueous 
dispersion as well. Zeta potential measures were also performed to establish the potential stability 
and polarity of the nanoparticles. It was found that the IC-SPIONs possessed positively charged 
surfaces with values of zeta potential of 21 ± 8 mV, probably due to the presence of protonated 
amines onto the nanoparticle surface. This value guarantees a good shelf stability of the system, along 
with the proper superficial charge helpful for the cellular up-take, which usually requires positively 
charged systems. 
Doxorubicin loaded IC-SPIONs were then prepared to establish the ability of the system to act as a 
drug-delivery system. Doxorubicin was used as anticancer drug model because it is also endowed 
with fluorescence properties, which can be exploited to evaluate its uptake into cells by means of 
fluorescence microscopy. The drug loading procedure was carried out adding the aqueous 
doxorubicin hydrochloride solution, previously treated with TEA, to the polymer/Fe3O4 mixture. A 
molar excess of TEA was added to drug solution in order to obtained doxorubicin free base, with a 
less water solubility, so becoming more affine to the hydrophobic portion of the coating consisting 
of the squalenoyl tails. The amount of drug loaded evaluated by UV analysis was found to be 
11.6 ± 0.5% (w/w), while the encapsulation efficiency was calculated to be 58.5%. DLS measurements 
carried out on Doxo-IC-SPIONs showed a reduction in size upon doxorubicin loading into 
nanoparticles, perhaps due to the formation of hydrophobic domains consisting of Sq moieties and 
aromatic portions of doxorubicin. Such interactions also explain well the higher polydispersity 
observed for the Doxo-IC-SPIONs (see Table 2). Being hydrophobic interactions concentration 
dependent phenomena, during the first step nanoparticles had available a large number of 
doxorubicin molecules which gave rise to compacted nanoparticles with high drug payload. After 
drug dilution, lesser drug–Sq interactions brought about bigger nanoparticles with a lower payload 
thus yielding to a high polydisperse system. As the lack of significant Z potential variations, which 
affects nanoparticles surface, endorsed the hypothesis that all changes provoked by doxorubicin 
involved the Doxo-IC-SPIONs core. 
 Table 2. - DLS data and zeta potential values of IC-SPIONs and Doxo-IC-SPIONs samples in aqueous medium at a final 
copolymer concentration of 0.2 mg/mL. 
 
Sample Hydrodynamic diameter (nm) PDI Zeta potential (mV) 
IC-SPIONs 54.19 0.16 21 ± 8 
Doxo-IC-SPIONs 44.15 0.46 19.8 ± 2 
 
The chemical composition of the hybrid nanoparticles, that is Doxo-IC-SPIONs and IC-SPIONs, was 
assessed by ferrozine colorimetric iron determination assay and for the latter also by FTIR 
spectroscopy. The total iron oxide amount in IC-SPIONs and Doxo-IC-SPIONs is revealed by the 
ferrozine assay, and was found to be equal to 6.5 ± 1% and 7.7 ± 1% on a weight basis respectively. 
The existence of the polymer coating on the IC-SPIONs surface was further investigated by FTIR 
analysis. In Fig. 2 the spectra are reported in comparison with Fe3O4 and INU-Sq-PEG2000 copolymer 
alone. The IR spectrum of Fe3O4 showed only the characteristic broad band of Fe O stretching at 
579 cm−1, whereas the INU-Sq-PEG2000 copolymer displays characteristic stretching bands of carbonyl 
functions at about 1650 and 1740 cm−1, coupled with some broad bands at 1100 cm−1, together with 
typical bands in the region of 1500–1200 cm−1. The spectrum of IC-SPIONs clearly showed the 
vibrating bands of the polymer consistent with the existence of a polymer coating on magnetite core. 
 
 
Fig. 2. - FTIR spectra of magnetite (Fe3O4), INU-Sq-PEG2000 copolymer and IC-SPIONs. (For interpretation of the references 
to color in this figure legend, the reader is referred to the web version of this article.) 
 
The superparamagnetic behavior of prepared IC-SPIONs was already evidenced macroscopically by 
the effect of an external magnetic field on their water dispersion. InFig. 3, photograph of IC-SPIONs 
dispersion is shown (a), clearly displaying that nanoparticles are well dispersed throughout the 
sample. It can be noticed that, after the application of an external magnetic field for some minutes, 
nanoparticles moved toward the magnet (b), whereas a homogeneous dispersion was obtained 
after the removal of the magnetic stimulus (c). 
 
 
Fig. 3. - Photographs of IC-SPIONs water dispersion before (a) during (b) and after (c) the application of an external 
magnetic field overnight. (For interpretation of the references to color in this figure legend, the reader is referred to the 
web version of this article.) 
 
3.3. Drug release studies 
To evaluate the capability of Doxo-IC-SPIONs to release the loaded model drug, release experiments 
were carried out in two media simulating different human body compartments. In particular, PBS 
solution at pH 7.4, which mimics physiological medium (Fig. 4a) and pH 5.5, mimicking endosomal 
and lysosomal environments were used (Fig. 4b). The release experiments at the two pH conditions 
consisted into quantify the amount of released doxorubicin in the external medium, at pre-
determined time intervals and until 48 h. In  Fig. 4a and b the amount of released doxorubicin, 
referred to the total amount of doxorubicin loaded into the micelles, is shown as function of the 
incubation time. The nanoparticles proved capable of releasing doxorubicin in the intact form for a 
prolonged period and without a first “burst effect”. For instance, after 48 h about 12% of doxorubicin 
payload was slowly released at the two pH conditions, providing good findings so as to guarantee the 
slow drug release once the site of action will be reached. Additionally, the release profile has not 
been affected by the pH of the medium. 
 
 
Fig. 4. - Drug release of Doxo-IC-SPIONs and doxorubicin hydrochloride in PBS solution at pH 7.4 (a) and at 
pH 5.5 (b). 
 
3.4. In vitro biological evaluations 
The effectiveness of the nanocarrier here prepared was established indirectly by evaluating the 
cytotoxicity of IC-SPIONs, Doxo-IC-SPIONs and doxorubicin hydrochloride on human colon cancer 
cells (HCT116), a cancer cell line used to investigate the anti-cancer activity of drugs and the 
associated mechanism of action [35], by MTS assay. MTS assay is based on the ability of mitochondrial 
dehydrogenases in viable cells to convert the MTS salt into a colored formazan product, which can 
be quantitatively detected by spectrophotometry at a λmax of 490 nm. The obtained absorbance is 
directly proportional to the number of living cells in culture. In Fig. 5 are reported the cytotoxicity 
profiles at 24 h and 48 h of incubation time of the plain drug at concentration in the range of 25–
200 μM ( 5a), IC-SPIONs at concentration within the range 0.13–1.08 mg/mL ( 5b), and Doxo-IC-
SPIONs ( 5c) at the same concentration above reported for IC-SPIONs, corresponding to the amount 
the doxorubicin tested in the positive control ( 5a). Fig. 5a shows that doxorubicin alone displayed a 
dose-dependent cytotoxicity profile passing from 32% of cell viability at the concentration of 25 μM 
to 0% at the concentration of 200 μM and 48 h of incubation. 
 
Fig. 5. - Cell viability % (MTS assay) on colon cancer cells (HCT116) of: doxorubicin hydrochloride (a), IC-SPIONs (b), Doxo-
IC-SPIONs (c) and all the samples previously mentioned in the presence and in the absence of the external magnet (d). 
Incubation times was 24 and 48 h. The results are reported as the mean ± SD (n = 6). ∗p = 0.0016, ∗∗p = 0.00018. 
 
For IC-SPIONs, negligible effect and no significant differences both after 24 and 48 h in cell viability 
were detected, at the whole concentration range tested, with respect the untreated control, 
indicating a good cytocompatibility of the empty system (Fig. 5b). 
While, the cytotoxicity profile obtained for increasing dose of Doxo-IC-SPIONs makes viewable a 
quasi-dose-independent trend of effectiveness (Fig. 5c), in particular after 48 h of incubation. The 
variation in cytotoxicity observed at different concentration was indeed within range of standard 
errors. Worthy of note is that the cytotoxicity observed after 48 h is higher than that revealed after 
24 h of incubation, thus suggesting that nanoparticles provide an intracellular reservoir of the drug, 
which is gradually released and internalized within nuclei. Moreover, even at the lower dosage, 
namely at 25 and 50 μM, the activity observed for Doxo-IC-SPIONs was remarkable higher, after 48 h 
of incubation, if compared with the same dose of plain drug, varying from 9% and 8% (Fig. 5c) to 20% 
and 16% (Fig. 5a) of viability respectively. This behavior clearly confirms that the loaded drug was 
locally and efficiently internalized into the cytosol compartment and there slowly released. 
Differently, free doxorubicin is rapidly internalized but also promptly expelled from the above 
compartment by the activation of the cell drug resistance mechanism, such as, for instance, those 
due to the efflux pump activity [36]. 
The same experiment was performed applying a permanent magnetic field at the bottom of the wells 
as shown in Fig. 5, in order to evaluate the effect of the magnetic field on cells viability. 
In particular, IC-SPIONs at concentration of 0.27 mg/mL and Doxo-IC-SPIONs at the same 
concentration, which corresponds to 50 μM in doxorubicin hydrochloride, were incubated for 24 h 
and 48 h either in the presence of a magnetic field or not. Results are reported in Fig. 5d with respect 
to cells treated with the magnetic field alone and cells treated with doxorubicin hydrochloride at 
concentration of 50 μM. All results are reported as function of the control, which is the cell viability 
of untreated cells. As can be seen from the Fig. 5d, the magnetic field applied both to the untreated 
cell culture and the cells treated with the IC-SPIONs did not affect cell viability, since the cell viability 
was definitely comparable to that of the control. As, the cytotoxic effect on HCT116 cells increases 
by about 50% when cells were incubated with Doxo-IC-SPIONs for 24 h in the presence of the external 
magnet, while the effectiveness was lower if compared with the same dose of free doxorubicin 
hydrochloride. On the other hand, the persistence of the external field for 48 h enhanced the 
effectiveness of the Doxo-IC-SPIONs (3.4 ± 0.1% of viability observed), being extensively higher than 
that expressed by the same dose of free doxorubicin hydrochloride (16.6 ± 1.7% in Fig. 5a). These 
results prove that the attractive force of the magnetic field on the magnetic particles that increase 
the particles penetration into cells [17] and [37], in combination with the slow drug release into cells 
above discussed, aids to an important improvement of the anticancer activity of doxorubicin. 
Finally, the ability of IC-SPIONs to release doxorubicin payload into HCT116 cells was confirmed by 
fluorescence microscopy analysis, incubating HCT116 cells with Doxo-IC-SPIONs, at drug 
concentration of 50 μM, both with and without the application of the external magnetic field. Fig. 
6 shows the image of cells after 4 (a), 24 (b) and 48 h (c) of incubation. These studies showed that 
free doxorubicin was rapidly accumulated in HCT116 nuclei just after 4 h of incubation (see line A 
of Fig. 6a), and no substantial differences in intracellular trafficking were observed after 24 and 48 h, 
apart from the reduction of live cells (line A of Fig. 6b and c). Differently, in the case of Doxo-IC-
SPIONs incubated without the external magnet, the higher fluorescence intensity is visualized in the 
cell cytoplasm after 4 h of incubation (see line B of Fig. 6a). The same result was obtained with Doxo-
IC-SPIONs incubated with the external magnet (see line C of Fig. 6a). After 24 h of incubation, a diffuse 
red fluorescence appeared inside cell nuclei also in cells treated with Doxo-IC-SPIONs (lines B and C 
of Fig. 6b), because doxorubicin was slowly released from nanoparticles. It is interesting to note that, 
in agreement with the cytotoxicity results above reported, the number of cells incubated with the 
external magnet appeared drastically reduced after 48 h of incubation (see line C of Fig. 6c), 
endorsing the hypothesis that the presence of the external magnetic force improves nanoparticles 
uptake. Moreover, it is well visible a red circle around the cell nuclei (see line C of Fig. 6c) presumably 
due to accumulation of Doxo-IC-SPIONs nanoparticle. This finding may confirmed the hypothesis that 
the magnetic force enhanced the Doxo-IC-SPIONs uptake and created a reservoir of the drug available 
inside cells that is slowly released into the nucleus, sustaining doxorubicin activity and eluding all 
possible drug resistance mechanisms. 
  
  
 
Fig. 6. - Fluorescence microscopy images of HCT116 cells incubated with free doxorubicin hydrochloride (line A), Doxo-
IC-SPIONs (line B) and Doxo-IC-SPIONs with the application of the external magnet (line C). incubation times were 4 (panel 
a), 24 (panel b) and 48 h (panel c). Doxorubicin (DOXO) is visualized in red; cell nuclei were stained with DAPI (blue). 
Magnification is 40× for all images. (For interpretation of the references to color in this figure legend, the reader is 
referred to the web version of this article.) 
 
4. Conclusions 
In this work, the synthesis of squalene-grafted-inulin copolymer bearing PEG2000moieties to give an 
amphiphilic copolymer with stealth like behavior is reported. This copolymer was easily obtained by 
in turn conjugating squalenoyl derivative and semitelechelic aldehyde terminated PEG chains of 
average weight molecular weight 2000, without employing drastic synthetic conditions. The 
introduction of squalenoyl tails in the hydrophilic backbone allowed obtaining a copolymer able to 
self-assemble into organized shell, once incubated with superparamagnetic iron oxide nanoparticles 
(SPIONs), leading to stable polymer coated SPIONs with average diameter of about 50 nm. We 
demonstrated that, in the presence of an external magnetic field, the system is strongly accumulated 
into a specific area of cell culturing, displaying a good magnetic targeting. Besides, although the 
release rate of doxorubicin from the system at physiological conditions appeared limited and slow, 
the system showed higher anticancer activity if compared with doxorubicin alone, especially under 
the effect of a magnetic field. On the whole, we clearly display that magnetic targeting implies 
advantageous therapeutic effects, that is amplified drug uptake, potential suppression of side effects 
and, consequently, increased anticancer activity throughout the tumor mass. 
 
 
Acknowledgements 
We thank the MIUR, the University of Turin (Ricerca locale 2013-14) and University of Palermo (FFR 
2012) for the financial support to this research. 
 
References 
[1] M.Z. Ahmad, S. Akhter, G.K. Jain, M. Rahman, S.A. Pathan, F.J. Ahmad, R.K. Khar.  
Metallic nanoparticles: technology overview & drug delivery applications in oncology. Expert Opin. Drug Deliv., 7 (2010), 
pp. 927–942 
[2] F. Si-Shen, S. Chien. Chemotherapeutic engineering: application and further development of chemical engineering 
principles for chemotherapy of cancer and other diseases. Chem. Eng. Sci., 58 (2003), pp. 4087–4114 
[3] S. Braunstein, L.J. Nakamura. Radiotherapy-induced malignancies: review of clinical features, pathobiology, and 
evolving approaches for mitigating risk. Front. Oncol. (2013), pp. 3–73 
[4] E.S. Kawasaki, A. Player. Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. 
Nanomed.: Nanotechnol. Biol. Med., 1 (2005), pp. 101–109 
[5] A. Kamb. Opinion: what’s wrong with our cancer models? Nat. Rev. Drug Discov., 4 (2005), pp. 161–165 
[6] M. Licciardi, C. Scialabba, C. Sardo, G. Cavallaro, G. Giammona. Amphiphilic inulin graft co-polymers as self-assembling 
micelles for doxorubicin delivery.  J. Mater. Chem., 2 (2014), pp. 4262–4271 
[7] E.F. Craparo, G. Teresi, M. Licciardi, M.L. Bondi’, G. Cavallaro. Novel composed galactosylated nanodevices containing 
a ribavirin prodrug as hepatic cell-targeted carriers for hcv treatment. J. Biomed. Nanotechnol., 9 (2013), pp. 1107–1122 
[8] D. Paolino, M. Licciardi, C. Celia, G. Giammona, M. Fresta, G. Cavallaro.  Folate-targeted supramolecular vesicular 
aggregates as a new frontier for effective anticancer treatment in “in vivo” model. Eur. J. Pharm. Biopharm., 82 (2012), 
pp. 94–102 
[9] J. Huwyler, J. Drewe, S. Krähenbühl. Tumor targeting using liposomal antineoplastic drugs. Int. J. Nanomed., 3 (2008), 
pp. 21–29 
[10] W.H. Chiang, W.-C. Huang, C.-W. Chang, M.-Y. Shen, Z.-F. Shih, Y.-F. Huang, S.C. Lin, H.C. Chiue. Functionalized 
polymerosomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and 
MR imaging. J. Control. Release, 3 (2013), pp. 280–288 
[11] Brannon-Peppas, J.O. Blanchette. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev., 56 
(2004), pp. 1649–1659 
[12] P.C. Griffiths, N. Mauro, D.M. Murphy, E. Carter, S.C.W. Richardson, P. Dyer, P. Ferruti. Self-assembled PAA-based 
nanoparticles as potential gene and protein delivery systems. Macromol. Biosci., 13 (2013), pp. 641–649 
[13] H. Maeda, J. Wu, T. Sawa, Y. Matsumura, K. Hori. Tumor vascular permeability and the EPR effect in macromolecular 
therapeutics: a review. J. Control. Release, 65 (2000), pp. 271–284 
 
[14] H. Maeda, T. Sawa, T. Konno. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR 
effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control. Release, 74 (2001), pp. 
47–61 
[15] R.H. Kodama. Magnetic nanoparticles. J. Magn. Magn. Mater., 200 (1999), pp. 359–372 
[16] L.W. Hamley. Nanotechnology with soft materials. Angew. Chem., 42 (2003), pp. 1692–1712 
[17] J. Riemer, H.H. Hepken, H. Czerwinska, S.R. Robinson, R. Dringen. Colorimetric ferrozine-based assay for the 
quantitation of iron in cultured cells. Anal. Biochem., 331 (2004), pp. 370–375 
[18] M. Licciardi, C. Scialabba, C. Fiorica, G. Cavallaro, G. Cassata, G. Giammona. Polymeric nanocarriers for magnetic 
targeted drug delivery: preparation, characterization, and in vitro and in vivo evaluation. 
Mol. Pharmacol., 10 (2013), pp. 4397–4407 
[19] M. Mahmoudi, S. Santc, B. Wang, S. Laurent, T. Sen. Superparamagnetic iron oxide nanoparticles (SPIONs): 
development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev., 63 (2011), pp. 24–46 
[20] L. Zhang, F. Gong, F. Zhang, J. Ma, P. Zhang, J. Shen. Targeted therapy for human hepatic carcinoma cells using folate-
functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro. Int. J. Nanomed., 8 
(2013), pp. 1517–1524 
[21] G.F. Li, J. Fan, R. Jiang, Y. Gao. Cross-linking the linear polymeric chains in the atrp synthesis of iron oxide/polystyrene 
core/shell nanoparticles. Chem. Mater., 16 (2010), pp. 1835–1837 
[22] S.R. Wan, Y. Zheng, Y. Liu, H. Yan, K. Liu. Fe3O4 nanoparticles coated with homopolymers of glycerol 
mono(meth)acrylate and their block copolymers. J. Mater. Chem., 15 (2005), pp. 3424–3430 
[23] M. van der Zee, J.H. Stoutjesdijk, P.A.A.W. van der Heijden, D. de Wit. Structure–biodegradation relationships of 
polymeric materials. 1. Effect of degree of oxidation on biodegradability of carbohydrate polymers. J. Environ. Polym. 
Degrad., 3 (1995), pp. 235–242 
[24] S. Kolida, G.R. Gibson. Prebiotic capacity of inulin-type fructans. J. Nutr., 137 (2007), pp. 2503S–2506S 
[25] G. Pitarresi, D. Triolo, M. Giorgi, C. Fiorica, F. Calascibetta, G. Giammona. Inulin-based hydrogel for oral delivery of 
flutamide: preparation, characterization, and in vivo release studies. Macromol. Biosci., 12 (2012), pp. 770–778 
[26] E.F. Craparo, G. Cavallaro, M.L. Bondi, D. Mandracchia, G. Giammona. Pegylated nanoparticles based on a 
polyaspartamide. Preparation, physico-chemical characterization, and intracellular uptake. Biomacromolecules, 7 (2006), 
pp. 3083–3092 
[27] D. Mandracchia, G. Tripodo, A. Latrofa, R. Dorati. Amphiphilic inulin-d-rmalpha-tocopherol succinate (invite) 
bioconjugates for biomedical applications. Carbohydr. Polym., 103 (2014), pp. 46–54 
[28] F.S. Palumbo, G. Pitarresi, D. Mandracchia, G. Tripodo, G. Giammona. New graft copolymers of hyaluronic acid and 
polylactic acid: synthesis and characterization. Carbohydr. Polym., 66 (3) (2006), pp. 379–385 
[29] J. Ren, P. Wang, F. Dong, Y. Feng, D. Peng, Z. Guo. Synthesis and antifungal properties of 6-amino-6-deoxyinulin, a 
kind of precursors for facile chemical modifications of inulin. Carbohydr. Polym., 87 (2012), pp. 1744–1748 
[30] J. Ren, J. Liu, F. Dong, Z. Guo. Synthesis and hydroxyl radicals scavenging activity of N-(aminoethyl)inulin. Carbohydr. 
Polym., 85 (2011), pp. 268–271 
[31] M. Ceruti, F. Rocco, F. Viola, G. Balliano, G. Grosa, F. Dosio, L. Cattel. Synthesis and biological activity of 19-
azasqualene 2,3-epoxide as inhibitor of 2,3-oxidosqualene cyclase. Eur. J. Med. Chem., 28 (1993), pp. 675–682 
[32] Cattel, M. Ceruti, G. Balliano, F. Viola, G. Grosa, F. Rocco, P. Brusa. 2,3-Oxidosqualene cyclase: from azasqualenes to 
new site-directed inhibitors. Lipids, 30 (1995), pp. 235–246 
[33] F. Viola, M. Ceruti, L. Cattel, P. Milla, K. Poralla, G. Balliano. Rationally designed inhibitors as tools for comparing the 
mechanism of squalene-hopene cyclase with oxidosqualene cyclase. Lipids, 35 (2000), pp. 297–303 
[34] P. Couvreur, L.H. Reddy, B. Pili, C. Bourgaux, M. Ollivon. Discovery of new hexagonal supramolecular nanostructures 
formed by squalenoylation of an anticancer nucleoside analogue. Small, 4 (2) (2008), pp. 247–253 
[35] G. Pitarresi, F.S. Palumbo, A. Albanese, C. Fiorica, P. Picone, G. Giammona. Self-assembled amphiphilic hyaluronic 
acid graft copolymers for targeted release of antitumoral drug. J. Drug Targeting, 18 (2010), pp. 264–276 
[36] F. Shen, S. Chu, A.K. Bence, B. Bailey, X. Xue, P.A. Erickson, M.H. Montrose, W.T. Beck, L.C. Erickson. Quantitation of 
doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. J. Pharmacol. Exp. 
Ther., 324 (2008), pp. 95–102 
[37] V. Sundaresana, J.U. Menon, M. Rahimi, K.T. Nguyena, A.S. Wadajkar. Dual-responsive polymer-coated iron oxide 
nanoparticles for drug delivery and imaging applications. Int. J. Pharm., 466 (2014), pp. 1–7 
 
